| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.1 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.092 | 0.1 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |